Kuang Shen to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Kuang Shen has written about Xenograft Model Antitumor Assays.
Connection Strength
0.027
-
Grabiner BC, Nardi V, Birsoy K, Possemato R, Shen K, Sinha S, Jordan A, Beck AH, Sabatini DM. A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity. Cancer Discov. 2014 May; 4(5):554-63.
Score: 0.027